AzTrials
AzTrials

Depression DisorderPREMA-PSYNCT07918365

The Effects of Extreme Prematurity on Parenting

An observational study of Depression Disorder and Post Traumatic Stress Disorder PTSD, run by Centre Hospitalier Universitaire de Besancon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

In France, perinatal mental health has become a major public health issue. Maternal mental health conditions can have serious consequences, including death by suicide. Fathers may also experience significant psychological distress during the perinatal period. Read more about this study

Who is it for?
Any age
How many people
30 participants
Where
No sites listed yet
Study dates
2 Nov 2026to 31 May 2027
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: Parent of a baby born at or before 28 weeks' gestation

Who may be able to join

  • To have recently become the parent of a baby born at or before 28 weeks' gestation
  • To be proficient in French
  • To have signed the study consent form

Who cannot join

  • - Persons deprived of their liberty by judicial or administrative decision; persons receiving involuntary psychiatric care
  • Adults subject to a legal protection measure or unable to express their consent
  • Patients who are not proficient in French
  • Refusal to participate in the study

About this study

In France, perinatal mental health has become a major public health issue. Maternal mental health conditions can have serious consequences, including death by suicide. Fathers may also experience significant psychological distress during the perinatal period. These difficulties can affect parents' well-being, the developing parent-infant relationship, and family life, highlighting the importance of early identification and appropriate support for both parents.

The birth of an infant before 28 completed weeks of gestation can be a traumatic experience for parents. Concerns about the infant's survival and health, together with the unfamiliar environment of a neonatal intensive care unit, can disrupt the transition to parenthood and may be associated with severe depressive symptoms and childbirth-related post-traumatic stress symptoms.

Read more

This single-centre observational study explores the psychological experiences of couples following the birth of an infant before 28 completed weeks of gestation. Its primary objective is to assess childbirth-related post-traumatic stress symptoms using the City Birth Trauma Scale. Secondary objectives are to assess depressive symptoms and explore parental representations, emotional experiences, and psychological functioning.

Couples will be invited to participate during their infant's hospitalisation in the neonatal intensive care unit at Besançon University Hospital, France. Both parents in each couple will participate, with individual assessments taking place at least one month after birth. Each assessment session will last approximately 90 minutes and will include a semi-structured interview using the Clinical Interview for Parents of High-Risk Infants (CLIP), the Rorschach test, and two self-report questionnaires: the Edinburgh Postnatal Depression Scale (EPDS) and the City Birth Trauma Scale, using the appropriate maternal or partner version.

This exploratory study aims to improve understanding of parental psychological vulnerability following extremely preterm birth. In the longer term, its findings may raise healthcare professionals' awareness of maternal and paternal distress and inform approaches to systematic screening for postnatal depression and childbirth-related post-traumatic stress symptoms. Ultimately, this research seeks to support the development of care that addresses both parents' psychological needs and promotes early parent-infant relationships.

Medical subject headings
Combat Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Childbirth related post-traumatic stress disorder

    The City Birth Trauma Scale (City BiTS) is a self-report questionnaire assessing childbirth-related post-traumatic stress symptoms according to DSM-5 criteria. It explores traumatic exposure, re-experiencing, avoidance, negative cognitions and mood, hyperarousal, symptom duration, distress, and functional impairment. Its 20 symptom items are scored from 0 to 3, yielding a total symptom score ranging from 0 to 60, with higher scores indicating greater symptom severity. In this study, the French versions for mothers and partners will be administered following very preterm birth. Total symptom scores will be analysed as a continuous measure. The questionnaire does not independently establish a clinical diagnosis of post-traumatic stress disorder.

    Measured: November 2026 to May 2027

Secondary outcomes (1)
  1. Postnatal Depression

    The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire assessing depressive symptoms over the past seven days. Each item is scored from 0 to 3, yielding a total score ranging from 0 to 30, with higher scores indicating greater symptom severity. It includes an item assessing thoughts of self-harm. In this study, the French version will be administered to mothers and fathers following very preterm birth to assess parental depressive symptoms. Total scores will be analysed as a continuous measure. The EPDS is a screening instrument and does not establish a clinical diagnosis of depression.

    Measured: November 2026 to May 2027

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2026
  2. Study start2 Nov 2026 (estimated)
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Family based
Time perspective
Prospective
Enrolment
30 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07918365
Sponsor's protocol ID
2026/1119
Acronym
PREMA-PSY
Status last verified
Oct 2026
First submitted
26 Oct 2026
Last updated
5 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depression Disorder and Post Traumatic Stress Disorder PTSD, run by Centre Hospitalier Universitaire de Besancon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Childbirth related post-traumatic stress disorder (time frame: November 2026 to May 2027). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in